Dr. Amy Yeung is an Assistant Professor of Medicine at Harvard Medical School and a pulmonary and critical care physician at Massachusetts General Hospital. She is Co-Director of the MGH Porphyria Center and specializes in the care of patients with porphyria, including erythropoietic protoporphyria (EPP) and acute hepatic porphyrias.

Dr. Yeung's clinical and research work focuses on improving the diagnosis, measurement, and treatment of porphyria. She is the principal investigator for multiple investigational clinical trials for EPP. She also leads clinical and translational studies focused on measuring light sensitivity and developing clinical trial outcomes in EPP, including the use of wearable light dosimetry, patient-reported outcomes, and biochemical biomarkers. Her broader porphyria research also includes studies of quality of life, reproductive health, diagnosis, biomarkers, and disease burden across multiple types of porphyria.

She is an investigator and Principal Investigator at the MGH Cutaneous Biology Research Center, where her laboratory studies the cellular and molecular mechanisms of cutaneous phototoxicity in protoporphyria. Her work integrates patient-derived samples, genomic data, cellular models, and functional assays to understand variability in disease severity and identify therapeutic targets.

Dr. Yeung received her MD from Vanderbilt University School of Medicine and her MPH in Quantitative Methods from the Harvard T.H. Chan School of Public Health. She completed internal medicine residency at the University of Washington and fellowship training in pulmonary and critical care medicine through the Harvard-MGH/BIDMC program. She works closely with national and international collaborators and with the United Porphyrias Association, a patient advocacy organization. She has EPP herself, which inspired her commitment to advancing porphyria research and patient care.